期刊文献+

Possible Mechanism Responsible for Changes of β-dystroglycanin Oral Squamous Cell Carcinoma

Possible Mechanism Responsible for Changes of β-dystroglycanin Oral Squamous Cell Carcinoma
下载PDF
导出
摘要 目的:探讨口腔鳞癌细胞中β-DG蛋白的存在状态及其分子机制。方法:在检测口腔鳞癌四株细胞系中β-DG蛋白存在状态的基础上,应用Western blot和蛋白质测序法研究基质金属蛋白酶(MMP)抑制剂1,10-phenanthroline对β-DG蛋白降解和癌细胞侵袭能力的逆转作用。结果:口腔鳞癌细胞中β-DG蛋白发生了降解,经MMP抑制剂1,10-phenanthroline作用后可以逆转β-DG蛋白降解和降低癌细胞的侵袭能力。蛋白测序证实,β-DG蛋白降解片段N端的氨基酸顺序为Ile-Asn-Thr-Asn或Ile-Val-Thr-Gln。结论:口腔鳞癌细胞中β-DG蛋白降解与癌细胞的侵袭和转移能力有关,MMP的剪切作用可能是β-DG蛋白降解的重要机制之一。 Objective: To investigate the correlation between β- dystroglycan degradation with invasiveness of tongue cancer ceils and its possible processing mechanism by MMP. Methods: β-dystroglycan degradation in SCC -4,9,15,25 was probed by western blot. Effects of MMP inhibitor 1,10- phenanthroline on the invasiveness of SCC -4,9,15,25 cell lines and β- dystroglycan degradation were investigated by in vitro invasion assay and immunoblot analysis, respectively. Coimmunoprecipitation and N - terminal sequencing were performed to determine the possible cleavage site of β- dystroglycan by MMP. Results: Western blot revealed an interesting 30 kDa fragment of β-dystroglycan (β-DG30) besides full β- dystroglycan (β- DGfull). The N-terminal sequence of β- DG30 was detected as Ile-Ash-Thr- Ash, or lie- Val -Thr- Gin by protein sequencing. In the presence of MMP inhibiror 1,10 -phenanthroline, β -dystroglycan degradation was abolished and the number of invasive tumour cells decreased significantly compared to controls. Conclusion: β- DG degradation is possibly correlated with invasiveness of tongue cancer cells. The MMP activity is partly responsible for the processing of full β- dystroglycan into β- DG30.
出处 《口腔医学研究》 CAS CSCD 2006年第1期50-54,共5页 Journal of Oral Science Research
关键词 β—DG 基质金属蛋白酶 口腔鳞状细胞癌 Dystroglycan Matrix metalloproteinase Oral squamous cell carcinoma
  • 相关文献

参考文献15

  • 1Hood JD, Cheresh DA. Role of integrins in cell invasion and migration [ J]. Nat Rev Cancer, 2002, 2:91 -100.
  • 2Christofori G. Changing neighbours, changing behaviour: cell adhesion molecule - mediated signalling during tumour progression [J]. EMBOJ, 2003, 22:2 318 -2 323.
  • 3Brennana PA, Jing J, Ethunandan M, Go'recki DC. Dystroglycan complex in cancer [J]. EJSO, 2004, 30:589-592.
  • 4Ibraghimov - Beskrovnaya O, Ervasti JM, Leveille C,J, et al.Primary structure of dystrophin - associated glycoproteins linking dystrophin to the extracellular matrix [ J ]. Nature, 1992, 355( 6362 ) : 696 - 702.
  • 5Winder SJ. The complexities of dystroglycan [ J ]. Trends Biochem Sci, 2001, 26:118 - 124.
  • 6Williamson RA, Henry MD, Daniels KJ, et al. Dystroglycan is essential for early embryonic development: disruption of Reiehert's membrane in Dagl -null mice [J]. Hum Mol Genet, 1997, 6:831 -841.
  • 7Durbeej M, Larsson E, lbraghimov - Beskrovnaya O, et al. Dystroglycan binding to laminin alphal LG4 module influences epithelial morphogenesis of salivary gland and lung in vitro [ J]. Differentiation, 2001, 69:121 - 134.
  • 8Durbeej M, Henry MD, Ferletta M, et al. Distribution of dystroglycan in normal adult mouse tissues [ J ]. J Histochem Cytochem, 1998, 46:449 -57.
  • 9Moore SA, Saito F, Chen J, et al. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy [ J ]. Nature, 2002, 418:422 - 425.
  • 10Henry MD, Campbell KP. A role for dystroglycan in basement membrane assembly [ J]. Cell, 1998, 95:859 - 870.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部